Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AC, Nerium SkinCare and OMHE are not related; I just wanted to prove that OMHE's Entourage Biotech is registered on the FDA site. Just to narrow my search, I used Nerium SkinCare in the search key along with OMHE's Entourage Biotech.
On Google.com search for below:
"entourage biotech" "Nerium SkinCare"
You will get one result. Click on that; it is a FDA Excel file = Open that Excel file, scroll down to line 9787.
Let me know if you cannot open it.
OMHE's Entourage Biotech Registered on FDA website
Open Attached Excel File then go to line 72215
Compare Agelock address with OMHE's official OTC Markets company address and both are same.
Agelock and OMHE OTC page addresses are same:
https://www.otcmarkets.com/stock/OMHE/profile
400 W 41st Street
Suite 506
Miami Beach, FL 33140
Facebook page address has no significance.
hey tinman...IMHO any news or the release of pending 10Q/K will disclose everything Omni has accomplished so far. It seems like Omni has acquired Entourage and Agelock but of course, we don't have any official update yet. But we can connect the dots....I have been waiting...because I can't do anything else :)
Ref. UR PM. 2 different Companies
OMHE owns Entourage Biotech, Inc.
And these two HUGE products:
https://trademarks.justia.com/owners/entourage-biotech-inc-3880764/
BIG DAY is COMING
OMHE_is_following_GW_Pharmas_footsteps_in_obtaning_CBD_based_Pain_Meds_FDA_Approval
GW Pharma's CBD based Meds FDA Approved Clinical Trial News
OMHE_is_the_Leader_of_Cannabinoid_Based_Pain_Treatment_Therapy/Medicine_Development
Link To News
OMHE's_R&D_is_in_$36Billion_Pain_Management_Global_Market
Link To News
OMHE_Developed_Cannabinoid-Based_Medicine_Headed_to_FDA_for_Approval
Link To News
OMHE_Announced_Acquisition_Plan_On_9/27_AND!!!!
Sep 27, 2018 PR Link
OMHE TO ANNOUNCE CASH_COW BIOTECH ACQUISITION?
Entourage Biotech, Inc. See Detailed PROOF>> Entourage Biotech, Inc.
Did you notice the name of the CEO?
RELIVATROL (being sold at Amazon too) is now owned by Entourage Biotech, Inc. >>PROOF
OMHE PPS will rise to $1 in few months
OMHE’s_ Cannabidiol_Products_To_Be_Exported_To_Europe._Capturing_Pain_Treatment_Market
Link To 11/14/2017 OMHE CEO Letter
OMHE_PPS_will_hit_$1_in_Few_Months____OMHE MMJ R&D Team
On 5/10/2017, SAB was formed and CEO had promised to expand "this Board with an elite group of industry, academic, and government experts" and on 6/1/2017, OMHE showed its commitment by inducting 2nd member to SAB. OMHE updated about another scientist in 11/14/2017 Letter.
SAB Member # 1: Dr. Arkady Uryash, MD, PhD
Dr. Uryash is the Director of Biomedical Research for the internship program of Mount Sinai Medical Center and Associate Professor of Cardiology and Vascular Biology for Mount Sinai Center in Miami. As an experienced Director of Research and Development, Dr. Uryash is knowledgeable in U.S. Food and Drug Administration (FDA) regulation, research and development, and clinical trials. Dr. Uryash has previously served as CEO of a biotech company and is experienced in the management of biotech company operations, interdisciplinary team recruitment, and intellectual property. He has published numerous articles in peer-review journals and is a recipient of several academic awards and honors.
SAB Member # 2: Dr. Lawrence E. Samuels, MD
Dr. Lawrence E. Samuels, the chief of dermatology at St. Luke's Hospital in St. Louis and a widely-respected leader in his medical field, founded RX Systems PF in 1966 and is highly knowledgeable in pH-balanced, Glypoic Complex-based products, retinols and moisturizers for the face and body, anti-aging, skin care and hair repair products. Dr. Samuels will provide access to a lucrative niche market of doctors' offices and medical facilities. Dr. Samuels is a member of the teaching faculty at Washington University Medical School and he has provided expert dermatological care for more than three decades. He's a board-certified dermatologist and a member of the American Academy of Dermatology and the American Society for Dermatologic Surgery.
SAB Member # 3: Dr. Karyemaitre Aliffe, MD
Dr. Aliffe is a forward-looking, Harvard University and Stanford University-trained, entrepreneurial physician-scientist executive with over 25 years of experience building corporate growth and profitability with strategic visionary leadership. His core competencies include practicable innovation enabling competitive expansion into lucrative niche markets while effectively harmonizing internal medical and therapeutic standards with regional and national regulatory guidelines. From the laboratory to the operating room, his specialty has always been translational biotherapeutics -- evidence-based, biopharmaceutical, phytomedicinal and medicinal nutraceutical development capturing health professional and consumer self-care markets across North America, Europe, Australia and Asia. An eloquent and effective multilingual communicator, Dr. Aliffe is also fluent in science and marketing, medicine and wellness, medicinal botany and clinical pharmacology, internet media and professional-to-consumer networking.
OMHE PPS will hit $1 in few months!!
OMHE_is_following_GW_Pharmas_footsteps_in_obtaning_CBD_based_Pain_Meds_FDA_Approval
GW Pharma's CBD based Meds FDA Approved Clinical Trial News
OMHE_PPS_will_be_$1_in_few_months_OMHE_is_Working_on_Licensed_MMJ_Cultivation
On 2/9/2017 OMHE CEO released 1st letter (Click Here to Read) to shareholders and most of the promises have been fulfilled as we can see Here and here in this 11/14/2017 CEO's 2nd Letter. One more the most important promise was licensed medical marijuana cultivation plan and I am expecting that will be implemented in next few months.
OMHE_is_The_Champion_of_6_Pharma_Industries_Applying _for_FDA_Approval_for_MMJ_Medicine
Check Their Website
1) Specialty Pharmacy
2) Regenerative Medicine
3) Anti-Aging
4) Skincare Technologies
5) Cannabis Technologies
6) Global Wellness
OMHE has scientists, R&D Lab, plan and is ready to market/sell Marijuana based Pain treatment therapeutics and medicine. Also, OTCQB upgrade is on the way!
12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here
OMHE PPS is Rising and will soon be $1
OMHE has an advanced Biotech R&D lab and scientists have developed cannabinoid-based drug therapies / medicines. Clinical Trial Started
Click to Read News>>>OMHE had announced all this in 2017
Thank you Autisticallycompetent
OMHE's future is high. Biotech acquisitions will bring PPS to $1
Two HUGE products of Entourage Biotech, Inc.
https://trademarks.justia.com/880/30/relivatrol-88030656.html
https://trademarks.justia.com/880/30/dr-88030689.html
Ironically_OMHE,_A_Junk_Stock_Is_Favorit_&_Most_Talked_About_HERE_IS_WHY!!
Because_OMHE_is_Not_A_Junk_Stock_HERE_IS_WHY!!
What to expect now? major news announcements including but not limited to Share restructuring, OTCQB Uplist, MMJ based Therapeutic Medicine R&D update, FDA Clinical Trial Progress update, Major business acquisitions that will doubled the yearly revenue.
OMHE owns a Biotech R&D lab and scientists are working in it to develop cannabinoid-based drug therapies / medicines.
In few months, after all these announcements OMHE PPS will be close to $1
OMHE is not a junk but the most profitable OTC stock!!!
OMHE will hit $1 PPS in few months.
PennyMaster OMHE's future is high!!!
Entourage Biotech, Inc. acquisition announcement will take PPS to the Sky!
Your Thoughts?
Evidence is here!!!!
Entourage Biotech, Inc. Check CEO Name here
OMHE. Check CEO Name here
Les, what are your thoughts on the following developments?
Sep 27, 2018 PR Link
OMHE TO ANNOUNCE BIOTECH ACQUISITION? Huge Success!!
Entourage Biotech, Inc. See Detailed PROOF>>
Entourage Biotech, Inc.
RELIVATROL (being sold at Amazon too) is now owned by Entourage Biotech, Inc. >>PROOF
Check who is the owner :)
OMHE PPS to hit $1 in few months
Thank_you_for_accepting_Entourage_Biotech_Inc_is_Huge
But Click on this to see who owns it now :)
OMHE_Announced_Acquisition_Plan_On_9/27_AND!!!!
Sep 27, 2018 PR Link
OMHE_OTCQB_Uplist_&_Share_Restructuring_Will_Be_Announced_Soon
Other expected major events include OTCQB uplist, share restructuring etc.
Check at OTC Site
No,_Previously_Relivatrol_was_owned_by_Celeb_Ventures_LLC
Dr.CBD_another_OMHE's_Entourage_Biotech_Inc_HUGE_PRODUCT
Click_Here_for_Proof
OMHE PPS will be $1 in few months!
OMHE TO ANNOUNCE CASH_COW BIOTECH ACQUISITION?
Entourage Biotech, Inc. See Detailed PROOF>> Entourage Biotech, Inc.
RELIVATROL (being sold at Amazon too) is now owned by Entourage Biotech, Inc. >>PROOF
OMHE PPS to hit $1 in few months
OMHE_Developed_Cannabinoid-Based_Medicine_Headed_for_FDA_Approval
Link To News
OMHE has an advanced Biotech R&D lab and scientists have developed cannabinoid-based drug therapies / medicines. Clinical Trial Started
Click to Read News>>>OMHE had announced all this in 2017
OMHE’s_Licensed_Medical_Marijuana_Cultivation_SOON
On 2/9/2017 OMHE CEO released 1st letter (Click Here to Read) to shareholders and most of the promises have been fulfilled as we can see Here and here in this 11/14/2017 CEO's 2nd Letter. One more the most important promise was licensed medical marijuana cultivation plan and I am expecting that will be implemented in next few months.
From 2/9/2017 Letter
OMHE is The Champion of 6 Pharmaceutical Industries
Check Their Website
1) Specialty Pharmacy
2) Regenerative Medicine
3) Anti-Aging
4) Skincare Technologies
5) Cannabis Technologies
6) Global Wellness
OMHE has scientists, R&D Lab, plan and is ready to market/sell Marijuana based Pain treatment therapeutics and medicine. Also, OTCQB upgrade is on the way!
PPS will touch $1 in few months!
Excellent_In_Depth_OMHE_Analysis_by_Autisticallycompetent
Thank you Autisticallycompetent
OMHE PPS will hit $1 in few months!
:) Thats_True_To_Understand_OMHE_one_needs_to_read_all_PRs
NEXT_PR_is_Expected_Anytime_WiLL_HAVE_HUGE_UPDATE_ABOUT_MMJ_based_Pain_Medicine_Development
OMHE_Demand_is_high_OMHE_Rose_11%_Nice!!!!
OMHE_Developed_Cannabinoid-Based_Medicine
In just few months OMHE PPS will hit $1
Rose 28% TODAY :)